A statistically significant correlation between the number of CTCs expressing Twist and vimentin in patients with both early stage and metastatic disease was demonstrated (P = 0.005 and P = 0.027, respectively), suggesting that both biomarkers were simultaneously expressed in CTCs. Here, VIM is linked to metastatic neoplasm.